2009
DOI: 10.1016/j.cancergencyto.2009.04.004
|View full text |Cite
|
Sign up to set email alerts
|

Cytogenetic effects of recombinant interferon-γ on lymphocytes cultures from patients with non–small cell lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2010
2010
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 37 publications
1
3
0
Order By: Relevance
“…These data were similar to the findings from earlier studies (Varga et al, 2011). PI has been used for the assessment of the cytostatic action of various therapeutic agents (Baka et al, 2009). C. islandica was useful and increased the PI, which was decreased by diabetes.…”
Section: Discussionsupporting
confidence: 90%
“…These data were similar to the findings from earlier studies (Varga et al, 2011). PI has been used for the assessment of the cytostatic action of various therapeutic agents (Baka et al, 2009). C. islandica was useful and increased the PI, which was decreased by diabetes.…”
Section: Discussionsupporting
confidence: 90%
“…The effects of IFN alone or combined with other treatment modalities (RT and CT) in NSCLC have been investigated. Arpin et al reported that IFN-γ did not display cytotoxic activity and that it may actually induce repair mechanisms (31). We found that IFN-γ levels significantly decreased following CRT only in GBM.…”
Section: Discussionmentioning
confidence: 44%
“…The question that then arises is how IFN␥ negatively regulates NP proliferation. One possibility is that IFN␥ induces cell-cycle arrest, an action that has been demonstrated previously in carcinoma cells (Burke et al, 1997;Shyu et al, 2000;Vivo et al, 2001;Baka et al, 2009) and mammalian epithelial cells (Harvat and Jetten, 1996). The anti-proliferative action in these cells is mainly regulated via activation of signal transducer and activator of transcription 1 (STAT1) and downregulation of cyclin A and cyclin E expression (Kortylewski et al, 2004).…”
Section: Discussionmentioning
confidence: 80%